Second primary tumors following tobacco dependence treatments among head and neck cancer patients

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 5, 2007, Pages 531-539

  Garces, Yolanda I ^a   Schroeder, Darrell R ^a   Nirelli, Liza M ^a   Croghan, Gary A ^a   Croghan, Ivana T ^a   Foote, Robert L ^a   Hurt, Richard D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Head and neck neoplasms; Multiple primary; Neoplasms; Second primary neoplasms; Smoking cessation

Indexed keywords

ABSTINENCE; ADULT; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CIGARETTE SMOKING; CONTROLLED STUDY; DEMOGRAPHY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HYPOPHARYNX CANCER; KIDNEY CANCER; LARYNX CANCER; LIP CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; OROPHARYNX CANCER; PANCREAS CANCER; PHARYNX CANCER; PROPORTIONAL HAZARDS MODEL; SALIVARY GLAND CANCER; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME; UTERINE CERVIX CANCER;

AGED; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; SMOKING CESSATION; TOBACCO USE DISORDER;

EID: 35148862138     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/COC.0b013e318059adfc     Document Type: Article

References (37)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA: A Cancer Journal for Clinicians. 2006;56:106-130.
2. Blot WJ, McLaughlin JK, Winn DM, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282-3287.
3. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin. Cancer. 1953;6:963-968.
4. Mashberg A, Samit A. Early diagnosis of asymptomatic oral and oropharyngeal squamous cancers. CA Cancer J Clin. 1995;45:328-351.
5. Newcomb PA, Carbone PP. The health consequences of smoking. Cancer. Med Clin North Am. 1992;76:305-331.
6. Khuri FR, Kim ES, Lee JJ, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 2001;10:823-829.
7. Franchin G, Minatel E, Gobitti C, et al. Radiotherapy for patients with early-stage glottic carcinoma: univariate and multivariate analyses in a group of consecutive, unselected patients. Cancer. 2003;98:765-772.
8. Day GL, Blot WJ, Shore RE, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst. 1994;86:131-137.
9. Schottenfeld D, Gantt RC, Wyner EL. The role of alcohol and tobacco in multiple primary cancers of the upper digestive system, larynx and lung: a prospective study. Prev Med. 1974;3:277-293.
10. Wynder EL, Mushinski MH, Spivak JC. Tobacco and alcohol consumption in relation to the development of multiple primary cancers. Cancer. 1977;40(suppl 4):1872-1878.
11. Tomek MS, McGuirt WF. Second head and neck cancers and tobacco usage. Am J Otolaryngol. 2003;24:24-27.
12. Garces YI, Schroeder DR, Nirelli LM, et al. Tobacco use outcomes among patients with head and neck carcinoma treated for nicotine dependence: a matched pair analysis. Cancer. 2004;101:116-124.
13. Dale LC, Ebbert JO, Hays JT, et al. Treatment of nicotine dependence. Mayo Clin Proc. 2000;75:1311-1316.
14. Hays JT, Wolter TD, Eberman KM, et al. Residential (inpatient) treatment compared with outpatient treatment for nicotine dependence. Mayo Clin Proc. 2001;76:124-133.
15. Hurt RD, Dale LC, McClain FL, et al. A comprehensive model for the treatment of nicotine dependence in a medical setting. Med Clin North Am. 1992;76:495-514.
16. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: toward an integrative model of change. J Consult Clin Psychol. 1983;51:390-395.
17. Greene FL, Balch CM, Page DL, et al., eds. AJCC Cancer Staging Manual, 6th ed. New York: Springer; 2002.
18. Patrick DL, Cheadle A, Thompson DC, et al. The validity of self-reported smoking: a review and meta-analysis. Am J Public Health. 1994;84:1086-1093.
19. Biochemical verification of tobacco use and cessation. Nicotine Tobacco Res. 2002;4:149-159.
20. Warren S, Gates O. Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer. 1932;16:1358-1414.
21. Annual smoking-attributable mortality, years of potential life lost, and economic costs: United States, 1995-1999. MMWR Morb Mortal Wkly Rep. 2002;51:300-303.
22. Keller SM, Vangel MG, Wagner H, et al. Second primary tumors following adjuvant therapy of resected stages II and IIIa non-small cell lung cancer. Lung Cancer. 2003;42:79-86.
23. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys. 1989;17:449-456.
24. Cox LS, Africano NL, Tercyak KP, et al. Nicotine dependence treatment for patients with cancer. Cancer. 2003;98:632-644.
25. Eifel PJ, Jhingran A, Bodurka DC, et al. Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer. J Clin Oncol. 2002;20:3651-3657.
26. Sanderson Cox L, Sloan JA, et al. Smoking behavior of 226 patients with diagnosis of stage IIIA/IIIB non-small cell lung cancer. Psycho-oncology. 2002;11:472-478.
27. van der Voet JC, Keus RB, Hart AA, et al. The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys. 1998;42:247-255.
28. Browman GP, Mohide EA, Willan A, et al. Association between smoking during radiotherapy and prognosis in head and neck cancer: a follow-up study. Head Neck. 2002;24:1031-1037.
29. Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328:159-163.
30. Videtic GM, Stitt LW, Dar AR, et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol. 2003;21:1544-1549.
31. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003;18:156-170.
32. Sanderson Cox L, Patten CA, Ebbert JO, et al. Tobacco use outcomes among patients with lung cancer treated for nicotine dependence. J Clin Oncol. 2002;20:3461-3469.
33. Gritz ER, Carr CR, Rapkin D, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev. 1993;2:261-270.
34. Do KA, Johnson MM, Lee JJ, et al. Longitudinal study of smoking patterns in relation to the development of smoking-related secondary primary tumors in patients with upper aerodigestive tract malignancies. Cancer. 2004;101:2837-2842.
35. Franke DL, Leistikow BN, Offord KP, et al. Physician referrals for smoking cessation: outcome in those who show and don't show. Prev Med. 1995;24:194-200.
36. Leong PP, Rezai B, Koch WM, et al. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma. J Natl Cancer Inst. 1998;90:972-977.
37. Tabor MP, Braakhuis BJ, van der Wal JE, et al. Comparative molecular and histological grading of epithelial dysplasia of the oral cavity and the oropharynx. J Pathol. 2003;199:354-360.